TY - JOUR
T1 - Cholera, diarrhea, and oral rehydration therapy
T2 - Triumph and indictment
AU - Guerrant, Richard L.
AU - Carneiro-Filho, Benedito A.
AU - Dillingham, Rebecca A.
PY - 2003/8/1
Y1 - 2003/8/1
N2 - Cholera drove the sanitary revolution in the industrialized world in the 19th century and now is driving the development of oral rehydration therapy (ORT) in the developing world. Despite the long history of cholera, only in the 1960s and 1970s was ORT fully developed. Scientists described this treatment after the discovery of the intact sodium-glucose intestinal cotransport in patients with cholera. This new understanding sparked clinical studies that revealed the ability of ORT to reduce the mortality associated with acute diarrheal disease. Despite the steady reductions in mortality due to acute dehydrating diarrheal diseases achieved by ORT, the costly morbidity due to these diseases remains, the result of a failure to globalize sanitation and to control the developmental impact of diarrheal diseases and their associated malnutrition. New advances in oral rehydration and nutrition therapy and new methods to recognize its costs are discussed in this review.
AB - Cholera drove the sanitary revolution in the industrialized world in the 19th century and now is driving the development of oral rehydration therapy (ORT) in the developing world. Despite the long history of cholera, only in the 1960s and 1970s was ORT fully developed. Scientists described this treatment after the discovery of the intact sodium-glucose intestinal cotransport in patients with cholera. This new understanding sparked clinical studies that revealed the ability of ORT to reduce the mortality associated with acute diarrheal disease. Despite the steady reductions in mortality due to acute dehydrating diarrheal diseases achieved by ORT, the costly morbidity due to these diseases remains, the result of a failure to globalize sanitation and to control the developmental impact of diarrheal diseases and their associated malnutrition. New advances in oral rehydration and nutrition therapy and new methods to recognize its costs are discussed in this review.
UR - http://www.scopus.com/inward/record.url?scp=0043162137&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0043162137&partnerID=8YFLogxK
U2 - 10.1086/376619
DO - 10.1086/376619
M3 - Review article
C2 - 12884165
AN - SCOPUS:0043162137
SN - 1058-4838
VL - 37
SP - 398
EP - 405
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 3
ER -